Key Highlights
- A five-day jury trial began Monday, with Qualcomm seeking to stop paying Arm royalties for up to five years.
- Qualcomm accuses Arm of withholding chip testing tools due under contract and leaking a 2024 license termination threat.
- Arm denies breaching the contract, says Qualcomm suffered no actual injury, and calls the claimed chip-deal damage speculative.
- Qualcomm's agreement with Arm runs through 2033, and a related bench trial covers whether Arm negotiated in good faith.
A Trial Begins in Delaware
Chipmaker Qualcomm and chip technology firm Arm Holdings, long at loggerheads, began another trial on Monday in US federal court in Wilmington, Delaware. Qualcomm accuses Arm of withholding chip testing tools that were due under contract. It also alleges that Arm leaked to the media its 2024 threat to terminate a vital license agreement, in a way that damaged discussions for a chip deal between Qualcomm and Meta Platforms.
Qualcomm, one of Arm's largest customers, is seeking to stop paying royalties to Arm for up to five years. The royalties are potentially worth billions of dollars.
Qualcomm's Opening
In Qualcomm's opening statement, its attorney directed the jury's attention to Qualcomm's 2021 acquisition of chip startup and Arm license holder Nuvia. She cited internal documents that she said showed Arm executives referring to Qualcomm as the enemy and fearing a collapse in royalty payments. She said Arm responded by breaching contracts and undermining Qualcomm's business relationship with Meta, including through coordinated leaks to the media. She asked jurors what they would do if their entire business depended on someone living up to promises and contracts.
Arm's Response
Arm's attorney said Qualcomm's case comes down to using litigation as leverage in a business dispute. He previewed evidence that he said showed Qualcomm did not suffer actual injury, and told the jury that the judge will instruct them they cannot find for Qualcomm unless it proves it was damaged by Arm's conduct.
Arm, which is owned by Japan's SoftBank Group, has denied that it breached the contract and argued that it did not damage Qualcomm's chip deals, which it described as speculative. It has also countered that Qualcomm cannot seek damages for the leak of the termination letter because Qualcomm leaked non-public details of antitrust probes into Arm to the media.
The Contract Term Before the Judge
Judge Maryellen Noreika is weighing whether to throw out the contract term behind the five-year hold on royalty payments that Qualcomm seeks. If the term is thrown out, Qualcomm would be able to seek only a smaller amount of damages.
A Long-Running Dispute
The five-day jury trial marks another stage in the contentious relationship between the two companies. Arm sued Qualcomm in 2022, alleging that Qualcomm had breached its contracts, though Qualcomm came away in 2024 with a key victory. In a related bench trial, the judge will also hear arguments over whether Arm has negotiated in good faith with Qualcomm for the next version of Arm's chip technology. Qualcomm's agreement with Arm runs through 2033.
Qualcomm is a major maker of chips for Android mobile phones but has expanded into other fields such as data center chips. Arm, which has for decades supplied fundamental chip design technology to Qualcomm and other chip firms such as Nvidia, has become a competitor to those customers by releasing chips of its own.
Final Analysis
The outcome of the five-day trial, along with the related bench trial on good-faith negotiation, may shape the terms of the companies' relationship through the remainder of their agreement to 2033. Industry observers may watch for the jury's findings and any ruling on the contested contract term.






Please wait processing your request...